Open Menu Close Menu

To identify and develop novel, safe and effective treatment paradigms for patients with hematological malignancies. The near term goal of this program is to advance the scientific and medical understanding of myeloid disease progression from an early stage to frank malignancy. *Note: IP terms accompany grant